img

Global HIV Therapy Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global HIV Therapy Market Insights, Forecast to 2034

HIV Therapy involves taking a combination of HIV medicines . HIV Therapy is recommended for everyone who has HIV. HIV Therapy cannot cure HIV, but HIV medicines help people with HIV live longer, healthier lives.
The global HIV Therapy market is projected to grow from US$ million in 2024 to US$ million by 2034, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for HIV Therapy is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for HIV Therapy is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for HIV Therapy is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The global key manufacturers of HIV Therapy include ViiV Healthcare, Gilead Sciences, Inc., GlaxoSmithKline Plc, Merck Sharp & Dohme Corp., Bristol-Myers Squibb Company, Janssen Pharmaceuticals, Inc., Boehringer Ingelheim International GmbH, AbbVie Inc. and Genentech, Inc., etc. In 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes


This report presents an overview of global market for HIV Therapy, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2024, and projections of CAGR through 2034.
This report researches the key producers of HIV Therapy, also provides the sales of main regions and countries. Highlights of the upcoming market potential for HIV Therapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the HIV Therapy sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2024. Identification of the major stakeholders in the global HIV Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2034. Evaluation and forecast the market size for HIV Therapy sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including ViiV Healthcare, Gilead Sciences, Inc., GlaxoSmithKline Plc, Merck Sharp & Dohme Corp., Bristol-Myers Squibb Company, Janssen Pharmaceuticals, Inc., Boehringer Ingelheim International GmbH, AbbVie Inc. and Genentech, Inc., etc.



By Company


ViiV Healthcare
Gilead Sciences, Inc.
GlaxoSmithKline Plc
Merck Sharp & Dohme Corp.
Bristol-Myers Squibb Company
Janssen Pharmaceuticals, Inc.
Boehringer Ingelheim International GmbH
AbbVie Inc.
Genentech, Inc.
Mylan N.V.
Segment by Type
Integrase Inhibitors
Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Combination HIV Medicines
Others

Segment by Application


Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of HIV Therapy in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3Detailed analysis of HIV Therapy manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8China by type, by application sales and revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, HIV Therapy sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Study Coverage
1.1 HIV Therapy Product Introduction
1.2 Market by Type
1.2.1 Global HIV Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Integrase Inhibitors
1.2.3 Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
1.2.4 Combination HIV Medicines
1.2.5 Others
1.3 Market by Application
1.3.1 Global HIV Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global HIV Therapy Sales Estimates and Forecasts 2018-2034
2.2 Global HIV Therapy Revenue by Region
2.2.1 Global HIV Therapy Revenue by Region: 2018 VS 2022 VS 2034
2.2.2 Global HIV Therapy Revenue by Region (2018-2024)
2.2.3 Global HIV Therapy Revenue by Region (2024-2034)
2.2.4 Global HIV Therapy Revenue Market Share by Region (2018-2034)
2.3 Global HIV Therapy Sales Estimates and Forecasts 2018-2034
2.4 Global HIV Therapy Sales by Region
2.4.1 Global HIV Therapy Sales by Region: 2018 VS 2022 VS 2034
2.4.2 Global HIV Therapy Sales by Region (2018-2024)
2.4.3 Global HIV Therapy Sales by Region (2024-2034)
2.4.4 Global HIV Therapy Sales Market Share by Region (2018-2034)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global HIV Therapy Sales by Manufacturers
3.1.1 Global HIV Therapy Sales by Manufacturers (2018-2024)
3.1.2 Global HIV Therapy Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of HIV Therapy in 2022
3.2 Global HIV Therapy Revenue by Manufacturers
3.2.1 Global HIV Therapy Revenue by Manufacturers (2018-2024)
3.2.2 Global HIV Therapy Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by HIV Therapy Revenue in 2022
3.3 Global Key Players of HIV Therapy, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global HIV Therapy Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global HIV Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of HIV Therapy, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of HIV Therapy, Product Offered and Application
3.8 Global Key Manufacturers of HIV Therapy, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global HIV Therapy Sales by Type
4.1.1 Global HIV Therapy Historical Sales by Type (2018-2024)
4.1.2 Global HIV Therapy Forecasted Sales by Type (2024-2034)
4.1.3 Global HIV Therapy Sales Market Share by Type (2018-2034)
4.2 Global HIV Therapy Revenue by Type
4.2.1 Global HIV Therapy Historical Revenue by Type (2018-2024)
4.2.2 Global HIV Therapy Forecasted Revenue by Type (2024-2034)
4.2.3 Global HIV Therapy Revenue Market Share by Type (2018-2034)
4.3 Global HIV Therapy Price by Type
4.3.1 Global HIV Therapy Price by Type (2018-2024)
4.3.2 Global HIV Therapy Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global HIV Therapy Sales by Application
5.1.1 Global HIV Therapy Historical Sales by Application (2018-2024)
5.1.2 Global HIV Therapy Forecasted Sales by Application (2024-2034)
5.1.3 Global HIV Therapy Sales Market Share by Application (2018-2034)
5.2 Global HIV Therapy Revenue by Application
5.2.1 Global HIV Therapy Historical Revenue by Application (2018-2024)
5.2.2 Global HIV Therapy Forecasted Revenue by Application (2024-2034)
5.2.3 Global HIV Therapy Revenue Market Share by Application (2018-2034)
5.3 Global HIV Therapy Price by Application
5.3.1 Global HIV Therapy Price by Application (2018-2024)
5.3.2 Global HIV Therapy Price Forecast by Application (2024-2034)
6 US & Canada
6.1 US & Canada HIV Therapy Market Size by Type
6.1.1 US & Canada HIV Therapy Sales by Type (2018-2034)
6.1.2 US & Canada HIV Therapy Revenue by Type (2018-2034)
6.2 US & Canada HIV Therapy Market Size by Application
6.2.1 US & Canada HIV Therapy Sales by Application (2018-2034)
6.2.2 US & Canada HIV Therapy Revenue by Application (2018-2034)
6.3 US & Canada HIV Therapy Market Size by Country
6.3.1 US & Canada HIV Therapy Revenue by Country: 2018 VS 2022 VS 2034
6.3.2 US & Canada HIV Therapy Sales by Country (2018-2034)
6.3.3 US & Canada HIV Therapy Revenue by Country (2018-2034)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe HIV Therapy Market Size by Type
7.1.1 Europe HIV Therapy Sales by Type (2018-2034)
7.1.2 Europe HIV Therapy Revenue by Type (2018-2034)
7.2 Europe HIV Therapy Market Size by Application
7.2.1 Europe HIV Therapy Sales by Application (2018-2034)
7.2.2 Europe HIV Therapy Revenue by Application (2018-2034)
7.3 Europe HIV Therapy Market Size by Country
7.3.1 Europe HIV Therapy Revenue by Country: 2018 VS 2022 VS 2034
7.3.2 Europe HIV Therapy Sales by Country (2018-2034)
7.3.3 Europe HIV Therapy Revenue by Country (2018-2034)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China HIV Therapy Market Size
8.1.1 China HIV Therapy Sales (2018-2034)
8.1.2 China HIV Therapy Revenue (2018-2034)
8.2 China HIV Therapy Market Size by Application
8.2.1 China HIV Therapy Sales by Application (2018-2034)
8.2.2 China HIV Therapy Revenue by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia HIV Therapy Market Size by Type
9.1.1 Asia HIV Therapy Sales by Type (2018-2034)
9.1.2 Asia HIV Therapy Revenue by Type (2018-2034)
9.2 Asia HIV Therapy Market Size by Application
9.2.1 Asia HIV Therapy Sales by Application (2018-2034)
9.2.2 Asia HIV Therapy Revenue by Application (2018-2034)
9.3 Asia HIV Therapy Sales by Region
9.3.1 Asia HIV Therapy Revenue by Region: 2018 VS 2022 VS 2034
9.3.2 Asia HIV Therapy Revenue by Region (2018-2034)
9.3.3 Asia HIV Therapy Sales by Region (2018-2034)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America HIV Therapy Market Size by Type
10.1.1 Middle East, Africa and Latin America HIV Therapy Sales by Type (2018-2034)
10.1.2 Middle East, Africa and Latin America HIV Therapy Revenue by Type (2018-2034)
10.2 Middle East, Africa and Latin America HIV Therapy Market Size by Application
10.2.1 Middle East, Africa and Latin America HIV Therapy Sales by Application (2018-2034)
10.2.2 Middle East, Africa and Latin America HIV Therapy Revenue by Application (2018-2034)
10.3 Middle East, Africa and Latin America HIV Therapy Sales by Country
10.3.1 Middle East, Africa and Latin America HIV Therapy Revenue by Country: 2018 VS 2022 VS 2034
10.3.2 Middle East, Africa and Latin America HIV Therapy Revenue by Country (2018-2034)
10.3.3 Middle East, Africa and Latin America HIV Therapy Sales by Country (2018-2034)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 ViiV Healthcare
11.1.1 ViiV Healthcare Company Information
11.1.2 ViiV Healthcare Overview
11.1.3 ViiV Healthcare HIV Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 ViiV Healthcare HIV Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 ViiV Healthcare Recent Developments
11.2 Gilead Sciences, Inc.
11.2.1 Gilead Sciences, Inc. Company Information
11.2.2 Gilead Sciences, Inc. Overview
11.2.3 Gilead Sciences, Inc. HIV Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Gilead Sciences, Inc. HIV Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Gilead Sciences, Inc. Recent Developments
11.3 GlaxoSmithKline Plc
11.3.1 GlaxoSmithKline Plc Company Information
11.3.2 GlaxoSmithKline Plc Overview
11.3.3 GlaxoSmithKline Plc HIV Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 GlaxoSmithKline Plc HIV Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GlaxoSmithKline Plc Recent Developments
11.4 Merck Sharp & Dohme Corp.
11.4.1 Merck Sharp & Dohme Corp. Company Information
11.4.2 Merck Sharp & Dohme Corp. Overview
11.4.3 Merck Sharp & Dohme Corp. HIV Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Merck Sharp & Dohme Corp. HIV Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Merck Sharp & Dohme Corp. Recent Developments
11.5 Bristol-Myers Squibb Company
11.5.1 Bristol-Myers Squibb Company Company Information
11.5.2 Bristol-Myers Squibb Company Overview
11.5.3 Bristol-Myers Squibb Company HIV Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Bristol-Myers Squibb Company HIV Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Bristol-Myers Squibb Company Recent Developments
11.6 Janssen Pharmaceuticals, Inc.
11.6.1 Janssen Pharmaceuticals, Inc. Company Information
11.6.2 Janssen Pharmaceuticals, Inc. Overview
11.6.3 Janssen Pharmaceuticals, Inc. HIV Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Janssen Pharmaceuticals, Inc. HIV Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Janssen Pharmaceuticals, Inc. Recent Developments
11.7 Boehringer Ingelheim International GmbH
11.7.1 Boehringer Ingelheim International GmbH Company Information
11.7.2 Boehringer Ingelheim International GmbH Overview
11.7.3 Boehringer Ingelheim International GmbH HIV Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Boehringer Ingelheim International GmbH HIV Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Boehringer Ingelheim International GmbH Recent Developments
11.8 AbbVie Inc.
11.8.1 AbbVie Inc. Company Information
11.8.2 AbbVie Inc. Overview
11.8.3 AbbVie Inc. HIV Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 AbbVie Inc. HIV Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 AbbVie Inc. Recent Developments
11.9 Genentech, Inc.
11.9.1 Genentech, Inc. Company Information
11.9.2 Genentech, Inc. Overview
11.9.3 Genentech, Inc. HIV Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Genentech, Inc. HIV Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Genentech, Inc. Recent Developments
11.10 Mylan N.V.
11.10.1 Mylan N.V. Company Information
11.10.2 Mylan N.V. Overview
11.10.3 Mylan N.V. HIV Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Mylan N.V. HIV Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Mylan N.V. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 HIV Therapy Industry Chain Analysis
12.2 HIV Therapy Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 HIV Therapy Production Mode & Process
12.4 HIV Therapy Sales and Marketing
12.4.1 HIV Therapy Sales Channels
12.4.2 HIV Therapy Distributors
12.5 HIV Therapy Customers
13 Market Dynamics
13.1 HIV Therapy Industry Trends
13.2 HIV Therapy Market Drivers
13.3 HIV Therapy Market Challenges
13.4 HIV Therapy Market Restraints
14 Key Findings in The Global HIV Therapy Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global HIV Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Integrase Inhibitors
Table 3. Major Manufacturers of Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Table 4. Major Manufacturers of Combination HIV Medicines
Table 5. Major Manufacturers of Others
Table 6. Global HIV Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global HIV Therapy Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global HIV Therapy Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global HIV Therapy Revenue by Region (2024-2034) & (US$ Million)
Table 10. Global HIV Therapy Revenue Market Share by Region (2018-2024)
Table 11. Global HIV Therapy Revenue Market Share by Region (2024-2034)
Table 12. Global HIV Therapy Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 13. Global HIV Therapy Sales by Region (2018-2024) & (K Units)
Table 14. Global HIV Therapy Sales by Region (2024-2034) & (K Units)
Table 15. Global HIV Therapy Sales Market Share by Region (2018-2024)
Table 16. Global HIV Therapy Sales Market Share by Region (2024-2034)
Table 17. Global HIV Therapy Sales by Manufacturers (2018-2024) & (K Units)
Table 18. Global HIV Therapy Sales Share by Manufacturers (2018-2024)
Table 19. Global HIV Therapy Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global HIV Therapy Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of HIV Therapy, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. HIV Therapy Price by Manufacturers 2018-2024 (US$/Unit)
Table 23. Global HIV Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global HIV Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Therapy as of 2022)
Table 25. Global Key Manufacturers of HIV Therapy, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of HIV Therapy, Product Offered and Application
Table 27. Global Key Manufacturers of HIV Therapy, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global HIV Therapy Sales by Type (2018-2024) & (K Units)
Table 30. Global HIV Therapy Sales by Type (2024-2034) & (K Units)
Table 31. Global HIV Therapy Sales Share by Type (2018-2024)
Table 32. Global HIV Therapy Sales Share by Type (2024-2034)
Table 33. Global HIV Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global HIV Therapy Revenue by Type (2024-2034) & (US$ Million)
Table 35. Global HIV Therapy Revenue Share by Type (2018-2024)
Table 36. Global HIV Therapy Revenue Share by Type (2024-2034)
Table 37. HIV Therapy Price by Type (2018-2024) & (US$/Unit)
Table 38. Global HIV Therapy Price Forecast by Type (2024-2034) & (US$/Unit)
Table 39. Global HIV Therapy Sales by Application (2018-2024) & (K Units)
Table 40. Global HIV Therapy Sales by Application (2024-2034) & (K Units)
Table 41. Global HIV Therapy Sales Share by Application (2018-2024)
Table 42. Global HIV Therapy Sales Share by Application (2024-2034)
Table 43. Global HIV Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global HIV Therapy Revenue by Application (2024-2034) & (US$ Million)
Table 45. Global HIV Therapy Revenue Share by Application (2018-2024)
Table 46. Global HIV Therapy Revenue Share by Application (2024-2034)
Table 47. HIV Therapy Price by Application (2018-2024) & (US$/Unit)
Table 48. Global HIV Therapy Price Forecast by Application (2024-2034) & (US$/Unit)
Table 49. US & Canada HIV Therapy Sales by Type (2018-2024) & (K Units)
Table 50. US & Canada HIV Therapy Sales by Type (2024-2034) & (K Units)
Table 51. US & Canada HIV Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada HIV Therapy Revenue by Type (2024-2034) & (US$ Million)
Table 53. US & Canada HIV Therapy Sales by Application (2018-2024) & (K Units)
Table 54. US & Canada HIV Therapy Sales by Application (2024-2034) & (K Units)
Table 55. US & Canada HIV Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada HIV Therapy Revenue by Application (2024-2034) & (US$ Million)
Table 57. US & Canada HIV Therapy Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 58. US & Canada HIV Therapy Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada HIV Therapy Revenue by Country (2024-2034) & (US$ Million)
Table 60. US & Canada HIV Therapy Sales by Country (2018-2024) & (K Units)
Table 61. US & Canada HIV Therapy Sales by Country (2024-2034) & (K Units)
Table 62. Europe HIV Therapy Sales by Type (2018-2024) & (K Units)
Table 63. Europe HIV Therapy Sales by Type (2024-2034) & (K Units)
Table 64. Europe HIV Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe HIV Therapy Revenue by Type (2024-2034) & (US$ Million)
Table 66. Europe HIV Therapy Sales by Application (2018-2024) & (K Units)
Table 67. Europe HIV Therapy Sales by Application (2024-2034) & (K Units)
Table 68. Europe HIV Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe HIV Therapy Revenue by Application (2024-2034) & (US$ Million)
Table 70. Europe HIV Therapy Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 71. Europe HIV Therapy Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe HIV Therapy Revenue by Country (2024-2034) & (US$ Million)
Table 73. Europe HIV Therapy Sales by Country (2018-2024) & (K Units)
Table 74. Europe HIV Therapy Sales by Country (2024-2034) & (K Units)
Table 75. China HIV Therapy Sales by Type (2018-2024) & (K Units)
Table 76. China HIV Therapy Sales by Type (2024-2034) & (K Units)
Table 77. China HIV Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 78. China HIV Therapy Revenue by Type (2024-2034) & (US$ Million)
Table 79. China HIV Therapy Sales by Application (2018-2024) & (K Units)
Table 80. China HIV Therapy Sales by Application (2024-2034) & (K Units)
Table 81. China HIV Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 82. China HIV Therapy Revenue by Application (2024-2034) & (US$ Million)
Table 83. Asia HIV Therapy Sales by Type (2018-2024) & (K Units)
Table 84. Asia HIV Therapy Sales by Type (2024-2034) & (K Units)
Table 85. Asia HIV Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia HIV Therapy Revenue by Type (2024-2034) & (US$ Million)
Table 87. Asia HIV Therapy Sales by Application (2018-2024) & (K Units)
Table 88. Asia HIV Therapy Sales by Application (2024-2034) & (K Units)
Table 89. Asia HIV Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia HIV Therapy Revenue by Application (2024-2034) & (US$ Million)
Table 91. Asia HIV Therapy Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 92. Asia HIV Therapy Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia HIV Therapy Revenue by Region (2024-2034) & (US$ Million)
Table 94. Asia HIV Therapy Sales by Region (2018-2024) & (K Units)
Table 95. Asia HIV Therapy Sales by Region (2024-2034) & (K Units)
Table 96. Middle East, Africa and Latin America HIV Therapy Sales by Type (2018-2024) & (K Units)
Table 97. Middle East, Africa and Latin America HIV Therapy Sales by Type (2024-2034) & (K Units)
Table 98. Middle East, Africa and Latin America HIV Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America HIV Therapy Revenue by Type (2024-2034) & (US$ Million)
Table 100. Middle East, Africa and Latin America HIV Therapy Sales by Application (2018-2024) & (K Units)
Table 101. Middle East, Africa and Latin America HIV Therapy Sales by Application (2024-2034) & (K Units)
Table 102. Middle East, Africa and Latin America HIV Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America HIV Therapy Revenue by Application (2024-2034) & (US$ Million)
Table 104. Middle East, Africa and Latin America HIV Therapy Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 105. Middle East, Africa and Latin America HIV Therapy Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America HIV Therapy Revenue by Country (2024-2034) & (US$ Million)
Table 107. Middle East, Africa and Latin America HIV Therapy Sales by Country (2018-2024) & (K Units)
Table 108. Middle East, Africa and Latin America HIV Therapy Sales by Country (2024-2034) & (K Units)
Table 109. ViiV Healthcare Company Information
Table 110. ViiV Healthcare Description and Major Businesses
Table 111. ViiV Healthcare HIV Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. ViiV Healthcare HIV Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. ViiV Healthcare Recent Developments
Table 114. Gilead Sciences, Inc. Company Information
Table 115. Gilead Sciences, Inc. Description and Major Businesses
Table 116. Gilead Sciences, Inc. HIV Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. Gilead Sciences, Inc. HIV Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Gilead Sciences, Inc. Recent Developments
Table 119. GlaxoSmithKline Plc Company Information
Table 120. GlaxoSmithKline Plc Description and Major Businesses
Table 121. GlaxoSmithKline Plc HIV Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. GlaxoSmithKline Plc HIV Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. GlaxoSmithKline Plc Recent Developments
Table 124. Merck Sharp & Dohme Corp. Company Information
Table 125. Merck Sharp & Dohme Corp. Description and Major Businesses
Table 126. Merck Sharp & Dohme Corp. HIV Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. Merck Sharp & Dohme Corp. HIV Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Merck Sharp & Dohme Corp. Recent Developments
Table 129. Bristol-Myers Squibb Company Company Information
Table 130. Bristol-Myers Squibb Company Description and Major Businesses
Table 131. Bristol-Myers Squibb Company HIV Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. Bristol-Myers Squibb Company HIV Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Bristol-Myers Squibb Company Recent Developments
Table 134. Janssen Pharmaceuticals, Inc. Company Information
Table 135. Janssen Pharmaceuticals, Inc. Description and Major Businesses
Table 136. Janssen Pharmaceuticals, Inc. HIV Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. Janssen Pharmaceuticals, Inc. HIV Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Janssen Pharmaceuticals, Inc. Recent Developments
Table 139. Boehringer Ingelheim International GmbH Company Information
Table 140. Boehringer Ingelheim International GmbH Description and Major Businesses
Table 141. Boehringer Ingelheim International GmbH HIV Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. Boehringer Ingelheim International GmbH HIV Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Boehringer Ingelheim International GmbH Recent Developments
Table 144. AbbVie Inc. Company Information
Table 145. AbbVie Inc. Description and Major Businesses
Table 146. AbbVie Inc. HIV Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 147. AbbVie Inc. HIV Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. AbbVie Inc. Recent Developments
Table 149. Genentech, Inc. Company Information
Table 150. Genentech, Inc. Description and Major Businesses
Table 151. Genentech, Inc. HIV Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 152. Genentech, Inc. HIV Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Genentech, Inc. Recent Developments
Table 154. Mylan N.V. Company Information
Table 155. Mylan N.V. Description and Major Businesses
Table 156. Mylan N.V. HIV Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 157. Mylan N.V. HIV Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Mylan N.V. Recent Developments
Table 159. Key Raw Materials Lists
Table 160. Raw Materials Key Suppliers Lists
Table 161. HIV Therapy Distributors List
Table 162. HIV Therapy Customers List
Table 163. HIV Therapy Market Trends
Table 164. HIV Therapy Market Drivers
Table 165. HIV Therapy Market Challenges
Table 166. HIV Therapy Market Restraints
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. HIV Therapy Product Picture
Figure 2. Global HIV Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global HIV Therapy Market Share by Type in 2022 & 2034
Figure 4. Integrase Inhibitors Product Picture
Figure 5. Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Product Picture
Figure 6. Combination HIV Medicines Product Picture
Figure 7. Others Product Picture
Figure 8. Global HIV Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 9. Global HIV Therapy Market Share by Application in 2022 & 2034
Figure 10. Hospital Pharmacies
Figure 11. Retail Pharmacies
Figure 12. Online Pharmacies
Figure 13. Others
Figure 14. HIV Therapy Report Years Considered
Figure 15. Global HIV Therapy Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 16. Global HIV Therapy Revenue 2018-2034 (US$ Million)
Figure 17. Global HIV Therapy Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 18. Global HIV Therapy Revenue Market Share by Region (2018-2034)
Figure 19. Global HIV Therapy Sales 2018-2034 ((K Units)
Figure 20. Global HIV Therapy Sales Market Share by Region (2018-2034)
Figure 21. US & Canada HIV Therapy Sales YoY (2018-2034) & (K Units)
Figure 22. US & Canada HIV Therapy Revenue YoY (2018-2034) & (US$ Million)
Figure 23. Europe HIV Therapy Sales YoY (2018-2034) & (K Units)
Figure 24. Europe HIV Therapy Revenue YoY (2018-2034) & (US$ Million)
Figure 25. China HIV Therapy Sales YoY (2018-2034) & (K Units)
Figure 26. China HIV Therapy Revenue YoY (2018-2034) & (US$ Million)
Figure 27. Asia (excluding China) HIV Therapy Sales YoY (2018-2034) & (K Units)
Figure 28. Asia (excluding China) HIV Therapy Revenue YoY (2018-2034) & (US$ Million)
Figure 29. Middle East, Africa and Latin America HIV Therapy Sales YoY (2018-2034) & (K Units)
Figure 30. Middle East, Africa and Latin America HIV Therapy Revenue YoY (2018-2034) & (US$ Million)
Figure 31. The HIV Therapy Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 32. The Top 5 and 10 Largest Manufacturers of HIV Therapy in the World: Market Share by HIV Therapy Revenue in 2022
Figure 33. Global HIV Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global HIV Therapy Sales Market Share by Type (2018-2034)
Figure 35. Global HIV Therapy Revenue Market Share by Type (2018-2034)
Figure 36. Global HIV Therapy Sales Market Share by Application (2018-2034)
Figure 37. Global HIV Therapy Revenue Market Share by Application (2018-2034)
Figure 38. US & Canada HIV Therapy Sales Market Share by Type (2018-2034)
Figure 39. US & Canada HIV Therapy Revenue Market Share by Type (2018-2034)
Figure 40. US & Canada HIV Therapy Sales Market Share by Application (2018-2034)
Figure 41. US & Canada HIV Therapy Revenue Market Share by Application (2018-2034)
Figure 42. US & Canada HIV Therapy Revenue Share by Country (2018-2034)
Figure 43. US & Canada HIV Therapy Sales Share by Country (2018-2034)
Figure 44. U.S. HIV Therapy Revenue (2018-2034) & (US$ Million)
Figure 45. Canada HIV Therapy Revenue (2018-2034) & (US$ Million)
Figure 46. Europe HIV Therapy Sales Market Share by Type (2018-2034)
Figure 47. Europe HIV Therapy Revenue Market Share by Type (2018-2034)
Figure 48. Europe HIV Therapy Sales Market Share by Application (2018-2034)
Figure 49. Europe HIV Therapy Revenue Market Share by Application (2018-2034)
Figure 50. Europe HIV Therapy Revenue Share by Country (2018-2034)
Figure 51. Europe HIV Therapy Sales Share by Country (2018-2034)
Figure 52. Germany HIV Therapy Revenue (2018-2034) & (US$ Million)
Figure 53. France HIV Therapy Revenue (2018-2034) & (US$ Million)
Figure 54. U.K. HIV Therapy Revenue (2018-2034) & (US$ Million)
Figure 55. Italy HIV Therapy Revenue (2018-2034) & (US$ Million)
Figure 56. Russia HIV Therapy Revenue (2018-2034) & (US$ Million)
Figure 57. China HIV Therapy Sales Market Share by Type (2018-2034)
Figure 58. China HIV Therapy Revenue Market Share by Type (2018-2034)
Figure 59. China HIV Therapy Sales Market Share by Application (2018-2034)
Figure 60. China HIV Therapy Revenue Market Share by Application (2018-2034)
Figure 61. Asia HIV Therapy Sales Market Share by Type (2018-2034)
Figure 62. Asia HIV Therapy Revenue Market Share by Type (2018-2034)
Figure 63. Asia HIV Therapy Sales Market Share by Application (2018-2034)
Figure 64. Asia HIV Therapy Revenue Market Share by Application (2018-2034)
Figure 65. Asia HIV Therapy Revenue Share by Region (2018-2034)
Figure 66. Asia HIV Therapy Sales Share by Region (2018-2034)
Figure 67. Japan HIV Therapy Revenue (2018-2034) & (US$ Million)
Figure 68. South Korea HIV Therapy Revenue (2018-2034) & (US$ Million)
Figure 69. China Taiwan HIV Therapy Revenue (2018-2034) & (US$ Million)
Figure 70. Southeast Asia HIV Therapy Revenue (2018-2034) & (US$ Million)
Figure 71. India HIV Therapy Revenue (2018-2034) & (US$ Million)
Figure 72. Middle East, Africa and Latin America HIV Therapy Sales Market Share by Type (2018-2034)
Figure 73. Middle East, Africa and Latin America HIV Therapy Revenue Market Share by Type (2018-2034)
Figure 74. Middle East, Africa and Latin America HIV Therapy Sales Market Share by Application (2018-2034)
Figure 75. Middle East, Africa and Latin America HIV Therapy Revenue Market Share by Application (2018-2034)
Figure 76. Middle East, Africa and Latin America HIV Therapy Revenue Share by Country (2018-2034)
Figure 77. Middle East, Africa and Latin America HIV Therapy Sales Share by Country (2018-2034)
Figure 78. Brazil HIV Therapy Revenue (2018-2034) & (US$ Million)
Figure 79. Mexico HIV Therapy Revenue (2018-2034) & (US$ Million)
Figure 80. Turkey HIV Therapy Revenue (2018-2034) & (US$ Million)
Figure 81. Israel HIV Therapy Revenue (2018-2034) & (US$ Million)
Figure 82. GCC Countries HIV Therapy Revenue (2018-2034) & (US$ Million)
Figure 83. HIV Therapy Value Chain
Figure 84. HIV Therapy Production Process
Figure 85. Channels of Distribution
Figure 86. Distributors Profiles
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries